Natural Alternatives International (NASDAQ:NAII) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a report released on Thursday morning. The brokerage issued a buy rating on the stock.

Natural Alternatives International Price Performance

Shares of NASDAQ:NAII opened at $4.30 on Thursday. Natural Alternatives International has a twelve month low of $4.11 and a twelve month high of $7.26. The stock’s 50 day moving average is $4.48 and its 200-day moving average is $5.43. The company has a quick ratio of 1.50, a current ratio of 2.56 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $26.66 million, a price-to-earnings ratio of -2.99 and a beta of 0.60.

Natural Alternatives International (NASDAQ:NAII) last issued its quarterly earnings data on Friday, September 27th. The company reported ($0.32) EPS for the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%. The company had revenue of $29.49 million for the quarter.

Institutional Investors Weigh In On Natural Alternatives International

A hedge fund recently raised its stake in Natural Alternatives International stock. Geode Capital Management LLC increased its stake in Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,062 shares of the company’s stock after purchasing an additional 2,915 shares during the quarter. Geode Capital Management LLC owned about 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent quarter. 32.40% of the stock is owned by institutional investors.

Natural Alternatives International Company Profile

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.